Todd M. Koelling

Todd M. Koelling

Auto-generated profile, based on publicly available information

Todd M. Koelling

Medical School University of Michigan Ann Arbor Michigan USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
MDMichael P Dorsch
Michael P Dorsch
KFKaren B Farris
Karen B Farris
BRBrigid E Rowell
Brigid E Rowell
SHScott L Hummel
Scott L Hummel
TKTodd M Koelling
Todd M Koelling
Background: The successful management of heart failure (HF) involves guideline-based medical therapy as well as self-management behavior. As a result, the management of HF is moving toward a proactive real-time technological model of assisting patients with monitoring and self-management. Objective: The aim of this paper was to evaluate the efficacy of enhanced self-management via a mobile app intervention on health-related quality of life, self-management, and HF readmissions. Methods: A single-center randomized controlled trial was performed. Participants older than 45 years and admitted for acute decompensated HF or recently discharged in the past 4 weeks were included. The intervention group (“app group”) used a mobile app, and the intervention prompted daily self-monitoring and promoted self-management. The control group (“no-app group”) received usual care. The primary outcome was the change in Minnesota Living with Heart Failure Questionnaire (MLHFQ) score from baseline to 6 and 12 weeks. Secondary outcomes were the Self-Care Heart Failure Index (SCHFI) questionnaire score and recurrent HF admissions. Results: A total of 83 participants were enrolled and completed all baseline assessments. Baseline characteristics were similar between the groups except for the prevalence of ischemic HF. The app group had a reduced MLHFQ at 6 weeks (mean 37.5, SD 3.5 vs mean 48.2, SD 3.7; P=.04) but not at 12 weeks (mean 44.2, SD 4 vs mean 45.9, SD 4; P=.78), compared to the no-app group. There was no effect of the app on the SCHFI at 6 or 12 weeks. The time to first HF readmission was not statistically different between the app group and the no-app group (app group 11/42, 26% vs no-app group 12/41, 29%; hazard ratio 0.89, 95% CI 0.39-2.02; P=.78) over 12 weeks. Conclusions: The adaptive mobile app intervention, which focused on promoting self-monitoring and self-management, improved the MLHFQ at 6 weeks but did not sustain its effects at 12 weeks. No effect was seen on HF self-management measured by self-report. Further research is needed to enhance engagement in the app for a longer period and to determine if the app can reduce HF readmissions in a larger study. Trial Registration: ClinicalTrials.gov NCT03149510; https://clinicaltrials.gov/ct2/show/NCT03149510

1 April 2015 in Telemedicine and e-Health
Verified
Journal Article
Open access
MDMichael P. Dorsch
Michael P. Dorsch
KFKaren B Farris
Karen B Farris
Barry BleskeBarry Bleske
Barry Bleske
TKTodd M. Koelling
Todd M. Koelling
Objective: The objective of this study was to determine if a Web application that promoted mindfulness of the progress of the chronic disease through self-monitoring improved quality of life in heart failure. Materials and Methods: This was a prospective single-center single-group study. Participants were instructed how to use the Web application and to perform self-monitoring daily for 12 weeks. A comprehensive physical exam, assessment of New York Heart Association (NYHA) class, the Minnesota Living with Heart Failure Questionnaire (MLHFQ), and an evaluation of self-management were performed in person at baseline and at 12 weeks. Results: Participants consisted of older (mean, 59 years), predominantly female (63%) adults with NYHA class II or III symptoms. NYHA classification (preintervention versus postintervention, 2.5±0.13 versus 2.0±0.13; p =0.0032) and MLHFQ score (55.7±4.6 versus 42.6±5.1, respectively; p =0.0078) improved over 12 weeks of self-monitoring. A trend toward improvement was also demonstrated in weight (preintervention versus postintervention, 209±9.6 pounds versus 207±9.4 pounds; by paired t test, p =0.389), number of times exercised per week (1.29±0.5 versus 2.5±0.6, respectively; p =0.3), and walk distance (572±147 yards versus 845±187 yards, respectively; p =0.119). Jugular venous distention (preintervention versus postintervention, 8.1±0.6 cm versus 6.7±0.3 cm; p =0.083) and peripheral edema (29.2% versus 16.7%, respectively; p =0.375) decreased after 12 weeks of self-monitoring via the Web application. Conclusions: A Web application for self-monitoring heart failure over 12 weeks improved both NYHA classification and MLHFQ score. The trend in improved physical activity and physical exam support these outcomes. The number of patients reporting a sodium-restricted diet increased over the 12 weeks, which may have led to the positive findings.

18 January 2026 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Open access
MAMohamed S. Ali
Mohamed S. Ali
KGKaitlyn M. Greer
Kaitlyn M. Greer
SGSabah Ganai
Sabah Ganai
TKTodd M. Koelling
Todd M. Koelling
SHScott L. Hummel
Scott L. Hummel
MDMichael P. Dorsch
Michael P. Dorsch
Aims: Guideline‐directed medical therapy (GDMT) implementation in heart failure with reduced ejection fraction (HFrEF) remains suboptimal. A computable algorithm was developed to generate a medication optimization score (MOS) and provide guideline‐based recommendations. This computable algorithm was previously validated using clinical trial data, and an updated version was developed in 2021 to include sodium‐glucose co‐transporter 2 inhibitors. This study evaluated the association between the medication optimization information generated by this version of the algorithm and clinical outcomes using real‐world data. Methods: We conducted a retrospective cohort study of 1352 ambulatory adult patients with chronic HFrEF who received care from the advanced heart failure service at the University of Michigan between July 1, 2021, and October 14, 2024. The algorithm‐generated MOS was calculated using electronic health record data. The primary outcome was a composite of all‐cause mortality or hospitalization. Cox proportional hazards models were used to evaluate the association between baseline MOS and the primary outcome. A time‐varying Cox model using the running cumulative MOS and a marginal structural model (MSM) was also conducted. A linear mixed‐effects model was used to assess improvement in MOS over time as the secondary outcome. Results: In the analysis adjusted for HF severity and comorbidities, baseline MOS was associated with a lower hazard of the composite outcome (hazard ratio (HR) 0.96, 95% confidence interval (95% CI): 0.92, 0.99, p = 0.040). In the cumulative time‐varying Cox model and the marginal structural model, the association with time‐varying MOS became stronger, with HRs of 0.88 (95% CI 0.81–0.95; p = 0.0015) and 0.88 (95% CI 0.83–0.93; p < 0.001), respectively. The event rates per 100 person‐years were 44.1 in MOS 0%–33%, 39.5 in MOS 34%–66%, and 31.8 in MOS 67%–100%. Longitudinally, MOS improved over time. Conclusion: Higher algorithm‐generated MOS values were significantly associated with lower all‐cause mortality or hospitalization, and the MOS values increased over the follow‐up period. This suggested that this algorithm effectively identifies opportunities for GDMT optimization in real‐world clinical settings.

1 December 2020 in JMIR Preprints
Verified
Preprint
Open access
MDMichael P Dorsch
Michael P Dorsch
KFKaren B Farris
Karen B Farris
BRBrigid E Rowell
Brigid E Rowell
SHScott L Hummel
Scott L Hummel
TKTodd M Koelling
Todd M Koelling
BACKGROUND The successful management of heart failure (HF) involves guideline-based medical therapy as well as self-management behavior. As a result, the management of HF is moving toward a proactive real-time technological model of assisting patients with monitoring and self-management. OBJECTIVE The aim of this paper was to evaluate the efficacy of enhanced self-management via a mobile app intervention on health-related quality of life, self-management, and HF readmissions. METHODS A single-center randomized controlled trial was performed. Participants older than 45 years and admitted for acute decompensated HF or recently discharged in the past 4 weeks were included. The intervention group (“app group”) used a mobile app, and the intervention prompted daily self-monitoring and promoted self-management. The control group (“no-app group”) received usual care. The primary outcome was the change in Minnesota Living with Heart Failure Questionnaire (MLHFQ) score from baseline to 6 and 12 weeks. Secondary outcomes were the Self-Care Heart Failure Index (SCHFI) questionnaire score and recurrent HF admissions. RESULTS A total of 83 participants were enrolled and completed all baseline assessments. Baseline characteristics were similar between the groups except for the prevalence of ischemic HF. The app group had a reduced MLHFQ at 6 weeks (mean 37.5, SD 3.5 vs mean 48.2, SD 3.7; P=.04) but not at 12 weeks (mean 44.2, SD 4 vs mean 45.9, SD 4; P=.78), compared to the no-app group. There was no effect of the app on the SCHFI at 6 or 12 weeks. The time to first HF readmission was not statistically different between the app group and the no-app group (app group 11/42, 26% vs no-app group 12/41, 29%; hazard ratio 0.89, 95% CI 0.39-2.02; P=.78) over 12 weeks. CONCLUSIONS The adaptive mobile app intervention, which focused on promoting self-monitoring and self-management, improved the MLHFQ at 6 weeks but did not sustain its effects at 12 weeks. No effect was seen on HF self-management measured by self-report. Further research is needed to enhance engagement in the app for a longer period and to determine if the app can reduce HF readmissions in a larger study. CLINICALTRIAL ClinicalTrials.gov NCT03149510; https://clinicaltrials.gov/ct2/show/NCT03149510